HIGHLIGHTS
- who: Agnieszka Zaczek and collaborators from the Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska St, Lodz, Poland have published the paper: Glucose and Cell Context-Dependent Impact of BMI-1 Inhibitor PTC-209 on AKT Pathway in Endometrial Cancer Cells, in the Journal: Cancers 2022, 5947 of /2022/
- what: In the study the glucose and cell context-dependent impact of the BMI-1 PTC-209 the in endometrial cancer cells was determined. Reduced PHLPP expression, which is a negative regulator of AKT, may be one of the main reasons . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.